DOCSLIB.ORG

Clinical Research Panel 4A

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Clinical Research Panel 4A Clinical Research Panel 4A Evaluation Division for Science Molecular Biology Botany, Zoology Panel 3 and Ecology-related Diciplines Panel 1 Public Health and Clinical Research Health-related Panel 4B Research Panel 5 Clinical Research Physiology-related Panel 4A Disciplines Panel 2 Psychology and Psychiatry Panel 6 Evaluation of biology, medicine and health research in Norway (2011) Clinical Research – Panel 4a All surgery, anaesthesiology, oncology, physical medicine and rehabilitation, gynaecology, paediatrics, dermatology and venereology, ophthalmology, otolaryngology and all clinical odontology, including corresponding translational research Evaluation of biology, medicine and health research in Norway (2011) © The Research Council of Norway 2011 The Research Council of Norway P.O.Box 2700 St. Hanshaugen N–0131 OSLO Telephone: +47 22 03 70 00 Telefax: +47 22 03 70 01 [email protected] www.rcn.no/english The report can be ordered at: www.forskningsradet.no/publikasjoner or green number telefax: +47 800 83 001 Design: Agendum as Printing: 07 Gruppen AS Number of copies: 500 Oslo, November 2011 ISBN 978-82-12-02993-4 (print) ISBN 978-82-12-02994-1 (pdf) Evaluation of biology, medicine and health research in Norway (2011) Contents PREFACE FROM THE RESEARCH COUNCIL OF NORWAY....................................................................................3 PREFACE FROM PANEL 4A................................................................................................................................4 STATEMENT FROM THE PANEL, WITH PANEL MEMBERS SIGNATURE ..............................................................5 EXECUTIVE SUMMARY WITH GENERAL CONCLUSIONS ....................................................................................7 GENERAL DESCRIPTION OF THE FIELD ..............................................................................................................8 GENERAL RECOMMENDATIONS.....................................................................................................................11 UNIVERSITY OF BERGEN, FACULTY OF MEDICINE AND DENTISTRY ....................................................................................12 Department of Clinical Dentistry...................................................................................................................12 Biomaterial................................................................................................................................................................ 13 Oral Infections and Inflammation.............................................................................................................................. 13 Patient and Community based Clinical Dental Research........................................................................................... 14 Tissue Engineering..................................................................................................................................................... 15 HAUKELAND UNIVERSITY HOSPITAL AND UNIVERSITY OF BERGEN, FACULTY OF MEDICINE AND DENTISTRY..............................16 The Gade Institute.........................................................................................................................................16 Cancer ....................................................................................................................................................................... 16 Institute of Medicine.....................................................................................................................................18 Hematology – Oncology group.................................................................................................................................. 19 Department of Clinical Medicine ..................................................................................................................20 Bergen Gynecologic Cancer Research Group ............................................................................................................ 21 Clinical Fetal Physiology Research Group.................................................................................................................. 23 Bergen Diabetes Research Group.............................................................................................................................. 24 Research Group for Pediatric Follow-up Studies....................................................................................................... 25 Research Group for Congenital Heart and Vascular Physiology................................................................................ 26 Section for Ophthalmology ....................................................................................................................................... 27 Department of Surgical Sciences...................................................................................................................29 Surgical outcome Research Group (SORG)- General Surgery .................................................................................... 30 Surgical outcome Research Group (SORG)- ENT/ H&N ............................................................................................. 30 The Norwegian Arthroplasty Register (NAR) ............................................................................................................. 31 Bergen Experimental Surgery Team - Thoracic Surgery ............................................................................................ 32 Bergen Experimental Surgery Team- Anesthesiology................................................................................................ 34 Neuro-Oncology Research Group.............................................................................................................................. 34 Bergen Upper-extremity Research Cluster (BURC).................................................................................................... 36 STAVANGER UNIVERSITY HOSPITAL............................................................................................................................38 The Surgical Research Group..................................................................................................................................... 38 UNIVERSITY OF OSLO, FACULTY OF DENTISTRY.............................................................................................................40 Institute of Clinical Dentistry.........................................................................................................................40 Craniofacial Clinical Research.................................................................................................................................... 40 Health Promotion and Disease Prevention ............................................................................................................... 41 OSLO UNIVERSITY HOSPITAL AND UNIVERSITY OF OSLO, FACULTY OF MEDICINE, INSTITUTE OF CLINICAL MEDICINE..................43 Division of Critical Care .................................................................................................................................43 Perioperative Medicine ............................................................................................................................................. 43 Acute Prehospital Medicine ...................................................................................................................................... 44 Pain management ..................................................................................................................................................... 45 Division of Surgery and Clinical Neuroscience ..............................................................................................46 Department of Orthopedics ...................................................................................................................................... 47 Department of Ophthalmology ................................................................................................................................. 48 Department of Ear, Nose, and Throat ....................................................................................................................... 49 Department of Physical Medicine and Rehabilitation............................................................................................... 49 Department of Neurosurgery.................................................................................................................................... 50 Women and Children’s Division ....................................................................................................................52 Gynecology and Obstetrics........................................................................................................................................ 52 Pediatrics................................................................................................................................................................... 54 Perinatal medicine..................................................................................................................................................... 55 Division of Surgery and Cancer Medicine......................................................................................................56 Oncology and Medical Physics .................................................................................................................................
Load more

Recommended publications
  • Norwegian Journal of Epidemiology Årgang 27, Supplement 1, Oktober 2017 Utgitt Av Norsk Forening for Epidemiologi
    1 Norsk Epidemiologi Norwegian Journal of Epidemiology Årgang 27, supplement 1, oktober 2017 Utgitt av Norsk forening for epidemiologi Redaktør: Trond Peder Flaten EN NORSKE Institutt for kjemi, D 24. Norges teknisk-naturvitenskapelige universitet, 7491 Trondheim EPIDEMIOLOGIKONFERANSEN e-post: [email protected] For å bli medlem av Norsk forening for TROMSØ, epidemiologi (NOFE) eller abonnere, send e-post til NOFE: [email protected]. 7.-8. NOVEMBER 2017 Internettadresse for NOFE: http://www.nofe.no e-post: [email protected] WELCOME TO TROMSØ 2 ISSN 0803-4206 PROGRAM OVERVIEW 3 Opplag: 185 PROGRAM FOR PARALLEL SESSIONS 5 Trykk: NTNU Grafisk senter Layout og typografi: Redaktøren ABSTRACTS 9 Tidsskriftet er åpent tilgjengelig online: LIST OF PARTICIPANTS 86 www.www.ntnu.no/ojs/index.php/norepid Også via Directory of Open Access Journals (www.doaj.org) Utgis vanligvis med to regulære temanummer pr. år. I tillegg kommer supplement med sammendrag fra Norsk forening for epidemiologis årlige konferanse. 2 Norsk Epidemiologi 2017; 27 (Supplement 1) The 24th Norwegian Conference on Epidemiology Tromsø, November 7-8, 2017 We would like to welcome you to Tromsø and the 24th conference of the Norwegian Epidemiological Association (NOFE). The NOFE conference is an important meeting point for epidemiologists to exchange high quality research methods and findings, and together advance the broad research field of epidemiology. As in previous years, there are a diversity of topics; epidemiological methods, cardiovascular disease, diabetes, cancer, nutrition, female health, musculo-skeletal diseases, infection and behavioral epidemiology, all within the framework of this years’ conference theme; New frontiers in epidemiology. The conference theme reflects the mandate to pursue methodological and scientific progress and to be in the forefront of the epidemiological research field.
    [Show full text]
  • Innkalling Og Forslag Til Saksliste HO21-Rådsmøte 28.02
    Til HelseOmsorg21-rådet Vår saksbehandler/tlf. Vår ref. Oslo, Hilde D.G. Nielsen, +4740922260/[email protected] 19/375 18.2.2019 Innkalling til HelseOmsorg21-rådsmøte 28.2.2019 (01/19) Vedlagt følger forslag til saksliste og sakspapirer til møte i HelseOmsorg21-rådet torsdag 28.2.2019 (01/19). Tid: kl 10.00 – 15.30. Sted: Forskningsrådet, Drammensveien 288, Lysaker. Vel møtt! Med vennlig hilsen Norges forskningsråd HelseOmsorg21-sekretariatet Hilde D. G. Nielsen, sekretariatsleder/spesialrådgiver Møte i HelseOmsorg21-rådet (01/19) Dato: Torsdag 28. februar 2019, kl 10.00 – 15.30 Sted: Forskningsrådet, Lysaker, møterom Abel 1 og 2 Saksliste Kl 10.00 – 10.15 Sak 01/19 Godkjenning av saksliste Sak 02/19 Godkjent referat Sak 03/19 Orienteringer Kl 10.15 – 11.00 Sak 04/19 Kunnskapssamarbeid med Kina Kl 11.00 – 12.00 Sak 05/19 Presentasjon og behandling av rapporten Research and Innovation for Better Health Lunsj kl 12.00-12.30 Kl 12.30 – 13.30 Sak 06/19 Presentasjon og behandling av sluttrapporten fra KSF Kort pause kl 13.30 – 13.45 Kl 13.45 - 14.45 Sak 07/19 HO21-rådets egenvurdering Kort pause kl 14.45 – 15.00 Kl 15.00 – 15.30 Sak 08/19 Orientering om status for arbeidet med stortingsmelding om innovasjon i offentlig sektor Kl 15.30 Sak 09/19 Eventuelt Saksfremlegg sak 02/19 – møte 01/19 Sak 02/19 Godkjent referat Type sak: Orienteringssak Til: HO21-rådet Fra: HO21-sekretariatsleder Hilde D.G. Nielsen Vedlegg: Godkjent referat fra møte 29.11.2018 (05/18) Referent: Sekretariatsleder Hilde D.G.
    [Show full text]
  • Gynaecology Healthcare Atlas 2015–2017 Helseatlas Hospital Referral Areas and Adjustment SKDE
    Gynaecology Healthcare Atlas 2015–2017 Helseatlas Hospital referral areas and adjustment SKDE The following fact sheets use the terms ‘hospital referral area’ and ‘adjusted for age’. These terms are explai- ned below. Aver. Hospital referral areas Inhabitants age Akershus 67% 201,911 47.2 The regional health authorities have a responsibility to provide satis- Vestre Viken 64% 196,644 48.6 Bergen 67% 178,531 46.7 factory specialist health services to the population in their catchment Innlandet 59% 166,569 50.3 area. In practice, it is the individual health trusts and private provi- Stavanger 70% 140,197 45.6 St. Olavs 66% 127,895 46.9 ders under a contract with a regional health authority that provide and Sørlandet 64% 120,307 47.8 Østfold 62% 119,927 49.2 perform the health services. Each health trust has a hospital referral OUS 72% 109,435 45.0 area that includes specific municipalities and city districts. Different Møre og Romsdal 61% 104,957 49.0 Vestfold 61% 95,564 49.3 disciplines can have different hospital referral areas, and for some ser- UNN 63% 77,413 48.2 Telemark 60% 71,665 49.8 vices, functions are divided between different health trusts and/or pri- Fonna 63% 70,749 48.2 vate providers. The Gynaecology Healthcare Atlas uses the hospital Hospital referral area Lovisenberg 84% 62,639 38.6 Diakonhjemmet 67% 59,811 46.3 referral areas for specialist health services for medical emergency ca- Nordland 61% 56,144 49.0 Nord-Trøndelag 61% 55,459 49.3 re.
    [Show full text]
  • Daming Jin Master Thesis
    Corporate Governance of Norwegian Health Trusts with Sector Political Goals Daming Jin Master thesis Department of Health Management and Health Economics UNIVERSITY OF OSLO May 15, 2011 SUMMARY Since 2002, the ownership of Norwegian hospitals has been centralized to the state. The four regional health authorities are responsible for the management of the hospitals, and the actual performance is done by the subsidiary health trusts (or HFs). As state-owned enterprises with certain sector political goals, the corporate governance of the health trusts is not exactly the same as private enterprises which mainly pursue pure business goals. The survey which the thesis uses investigates the HF board members’ opinions on some issues of sector political goals and corporate governance. The main purpose of this thesis is to find the differences of the opinions among different groups of HF board members, and to study whether the differences are consistent with relevant theories such as motivation and management theories. The data of the thesis is based on a questionnaire of the survey program Management of State-owned enterprises with sector political goals. The respondents of the survey cover all HF board members who are the target population of my research. Several quantitative methods, such as descriptive statistics and non-parametric tests, are chosen to detect the HF board members’ opinions and the differences of their opinions on the issues of sector political goals and corporate governance. The analyses mainly show that, the appointed board members with macro and broad perspective pay more attention to sector political goals than the employee representatives with micro and specific perspective do.
    [Show full text]
  • Response of the Norwegian Government to the Report of the European Committee for the Prevention of Torture and Inhuman Or Degrad
    CPT/Inf (2019) 22 Response of the Norwegian Government to the report of the European Committee for the Prevention of Torture and Inhuman or Degrading Treatment or Punishment (CPT) on its visit to Norway from 28 May to 5 June 2018 The Norwegian Government has requested the publication of this response. The CPT’s report on the May/June 2018 visit to Norway is set out in document CPT/Inf (2019) 1. Strasbourg, 28 June 2019 Response of the Norwegian authorities to the report of the European Committee for the Prevention of Torture and Inhuman or Degrading Treatment or Punishment’s (CPT) periodic visit to Norway from 28th May to 5th June 2018. Item 7 - The CPT trusts that the Norwegian authorities will take all necessary steps to ensure that, also in the future, visiting delegations of the Committee will have unrestricted access to medical files in all types of establishments where persons may be deprived of their liberty, as had been the case during this and all previous visits by the CPT to Norway. Reply: Norway's interpretation of Article 8, paragraph 2, sub-paragraph (d) of the Convention is that it entails no obligation to grant the Committee unlimited access to documents and information, regardless of Norwegian rules of confidentiality. Both Article 8, paragraph 2, sub-paragraph (d) of the Convention and paragraph 64 of the Explanatory Report to the Convention acknowledge that member States have different rules concerning disclosure of information, and it is stated that the Committee shall take such rules into consideration when seeking information.
    [Show full text]
  • Adoption of Routine Telemedicine in Norway: the Current Picture
    Global Health Action æ ORIGINAL ARTICLE Adoption of routine telemedicine in Norway: the current picture Paolo Zanaboni1*, Undine Knarvik1 and Richard Wootton1,2 1Norwegian Centre for Integrated Care and Telemedicine, University Hospital of North Norway, Tromsø, Norway; 2Faculty of Health Sciences, University of Tromsø, Tromsø, Norway Background: Telemedicine appears to be ready for wider adoption. Although existing research evidence is useful, the adoption of routine telemedicine in healthcare systems has been slow. Objective: We conducted a study to explore the current use of routine telemedicine in Norway, at national, regional, and local levels, to provide objective and up-to-date information and to estimate the potential for wider adoption of telemedicine. Design: A top-down approach was used to collect official data on the national use of telemedicine from the Norwegian Patient Register. A bottom-up approach was used to collect complementary information on the routine use of telemedicine through a survey conducted at the five largest publicly funded hospitals. Results: Results show that routine telemedicine has been adopted in all health regions in Norway and in 68% of hospitals. Despite being widely adopted, the current level of use of telemedicine is low compared to the number of face-to-face visits. Examples of routine telemedicine can be found in several clinical specialties. Most services connect different hospitals in secondary care, and they are mostly delivered as teleconsultations via videoconference. Conclusions: Routine telemedicine in Norway has been widely adopted, probably for geographical reasons, as in other settings. However, the level of use of telemedicine in Norway is rather low, and it has significant potential for further development as an alternative to face-to-face outpatient visits.
    [Show full text]
  • National Brain Health Strategy (2018-2024)
    National Brain Health Strategy (2018-2024) Contents 1 Introduction 7 2 A changing and developing society 11 3 Objective 1: Good lifelong brain health, prevention and quality of life 15 4 Objective 2: A more user-centred healthcare service and better care of relatives 20 5 Objective 3: Good care from the onset of symptoms to diagnosis and treatment, to habilitation and rehabilitation 26 6 Objective 4: Adequate knowledge and quality through research and innovation 34 7 Overview of closely-related work 41 References 42 The smart device It is with you everywhere you go. It’s with in the morning when you’re trying to get out the door with the kids, in the afternoon when you cut your finger chopping onions in the kitchen, and in the evening when you stumble towards the bedroom a little too late. It keep tracks of work and leisure‚ reminds you of meetings to be held and reports to be written. It remembers the little one’s training times and the housing cooperative’s notice about voluntary work. It helps you to do your job. It helps you to keep track of your body. It helps you live. It remembers the ones most dearest to you. What you love the most. I am not referring to a smartphone. I am talking about something far more complex and far more advanced. I am referring to your brain. The device that is smarter than the most intelligent smartphone. When the brain is affected by disease or injury, a lot is affected. Getting the kids off to school in the morning and cooking dinner in the afternoon goes from normal to an oddity.
    [Show full text]
  • The Bomb Attack in Oslo and the Shootings at Utøya, 2011
    The bomb attack in Oslo and the shootings at Utøya, 2011 KAMEDO report 97 Kamedo – the Swedish Disaster Medicine Study Organisation – has existed since 1964 and was previously known as the Swedish Disaster Medicine Organisation Committee. The committee started its activities under the auspices of the Swedish Research Delegation for Defence Medicine. In 1974 Kamedo was transferred to FOA (the Swedish Defence Research Establishment), now called FOI (the Swedish Defence Research Agency). Kamedo has been affiliated with the National Board of Health and Welfare since 1988. The main task of Kamedo is to send expert observers to places in the world affected by large-scale accidents or disasters. The observers are sent to disaster areas at short notice and collect relevant information by contacting key individuals, principally on a colleague-to-colleague basis. The information they obtain may only be used for documentation purposes. There are four main areas which are studied first and foremost: the medical, psychological, organisational and social aspects of disasters. Results from the studies are published in Kamedo reports that are listed on the National Board of Health and Welfare’s website. As of report number 74 the full reports may be downloaded, but for the earlier reports only the summary is available on the website. From report number 34 and onward they have a summary in English and as of report number 55 these are downloadable from the website. From number 89 and onward the whole reports have been translated into English. The authors are responsible for the contents and conclusions, the National Board of Health and Welfare draws no conclusions in the document.
    [Show full text]
  • The Nonprofit Theory Revisited the Advantages and Challenges for the Third Sector Second Edition
    REPORT The Nonprofit Theory Revisited The Advantages and Challenges for the Third Sector Second Edition MENON PUBLICATION NO. 44/2012 By Rasmus Bøgh Holmen Examples of Norwegian Third Sector Actors Examples of International Third Sector Actors Menon Business Economics II REPORT The Nonprofit Theory Revisited The Advantages and Challenges for the Third Sector Rasmus Bøgh Holmen Second Edition First Edition Research Report Master Thesis Menon Report No. Master Degree in 44/2012 Economic Theory and Econometrics December 12 February 12 Ownership and Capital Team at Menon Business Department of Economics Economics at the University of Oslo Menon Business Economics III REPORT The Nonprofit Theory Revisited – The Advantages and Challenges for the Third Sector Second Edition December 12 Online: http://www.menon.no Press: Please send mail to [email protected] for printed version First edition February 12 Online: http://www.duo.uio.no Press: University Print Centre at the University of Oslo © Rasmus Bøgh Holmen Menon Business Economics IV REPORT Illustrating Quotes ‘My view is that nonprofits organizations are largely a way of solving informational problems. Managers of nonprofit organizations lack the incentive of profit that might otherwise tempt them to misrepresent their products or services’ (Weisbrod 1988, page vii). Burton A. Weisbrod Henry B. Hansmann Northwestern University Yale University ‘In spite of the limitation imposed upon them, nonprofits may succeed in distributing some of their net earnings through inflated salaries, various perquisites granted to employees and other forms of excess payments’ (Hansmann 1980, page 844). Menon Business Economics V REPORT Abstract In this report, I draw attention to nonprofits with core focus on the ones that are operating in the business sector.
    [Show full text]
  • The Western Norway Regional Health Authority
    The Western Norway Regional Health Authority The Western Norway Regional Health Authority (WNRHA, "Helse Vest") has overall responsibility for providing specialist healthcare services in the counties of Rogaland, Hordaland and Sogn og Fjordane. Its role is to ensure that people in the region have access to the services that they are legally entitled to. Helse Vest owns the six health trusts in the region and provides them with group management services. It also owns the ICT provider Helse Vest IKT AS. The health trusts employ around 27,500 health service staff. The authority’s total budget is approximately NOK 25 billion. Around 50 people are employed directly by the authority, which is based at Forus in Stavanger. Helse Vest is one of four regional health authorities in Norway and reports to the Ministry of Health and Care Services. The six health trusts within Helse Vest in addition to Helse Vest IKT AS are: Bergen Hospital Trust Fonna Hospital Trust Førde Hospital Trust Stavanger Hospital Trust Trust Sjukehusapoteka Vest (Hospital Pharmacies) Trust Helse Vest Procurement (est. April 2015) The health trusts in the region own and operate around 50 public hospitals and other health institutions, and they provide health care to a population of approximately 1.1 million. Overall objectives and priorities Patient treatment Health personnel training Research Training of patients and next of kin Mission and vision Mission: Helse Vest should provide effective and future-orientated high-quality health services. The services should contribute to good health and quality of life, and they should promote self-rehabilitation. Vision: Helse Vest delivers the very best in service, quality and research and is your preferred health services provider.
    [Show full text]
  • Anne Kathrine Larssen Bygg Og Eiendoms Betydning for Effektiv Sykehusdrift Buildings' Impact on Hospital Effectiveness
    Doktoravhandlinger ved NTNU, Anne Kathrine Larssen Anne Kathrine Larssen Bygg og eiendoms betydning for effektiv sykehusdrift Buildings' Impact on Hospital Effectiveness ISBN 978-82-471-2886-2 (trykt utg.) ISBN 978-82-471-2888-6 (elektr. utg.) ISSN 1503-8181 Doktoravhandlinger ved NTNU, ved Doktoravhandlinger NTNU universitet philosophiae doctor philosophiae Avhandling for graden for Avhandling Norges teknisk-naturvitenskapelige Norges Institutt for bygg, anlegg og transport bygg, anlegg for Institutt Fakultet for ingeniørvitenskap og teknologi ingeniørvitenskap for Fakultet Anne Kathrine Larssen Bygg og eiendoms betydning for effektiv sykehusdrift Buildings' Impact on Hospital Effectiveness Avhandling for graden philosophiae doctor Trondheim, juni 2011 Norges teknisk-naturvitenskapelige universitet Fakultet for ingeniørvitenskap og teknologi Institutt for bygg, anlegg og transport NTNU Cdg\ZhiZ`c^h`"cVijgk^iZch`VeZa^\Zjc^kZgh^iZi 6k]VcYa^c\[dg\gVYZce]^adhde]^VZYdXidg ;V`jaiZi[dg^c\Zc^©gk^iZch`Ved\iZ`cdad\^>KI >chi^ijii[dgWn\\!VcaZ\\d\igVchedgi 6ccZ@Vi]g^cZAVghhZc >H7C.,-"-'"),&"'--+"'ign`iji\# >H7C.,-"-'"),&"'---"+ZaZ`igji\# >HHC&*%("-&-& 9d`idgVk]VcYa^c\ZgkZYCICJ!'%&&/&,% Ign`iVkIVe^gJiign`` Bygg og eiendoms betydning for effektiv sykehusdrift PhD avhandling Anne Kathrine Larssen Fakultet for ingeniørvitenskap og teknologi, institutt for bygg, anlegg og transport NTNU 2011 Larssen, A. K. – Bygg og eiendoms betydning for effektiv sykehusdrift Forord Dette PhD – arbeidet har ført meg ut på en lang reise, både i tid og i faglig utvikling, fra oppstarten for nærmere 10 år siden til i dag. Underveis har jeg fått muligheten til å fordype meg i interessante tema og fått mange nye bekjentskaper jeg setter stor pris på. Reisen har tatt så lang tid av flere årsaker, blant annet familieforøkelser, bortfall av opprinnelig finansiering, tidkrevende prosesser med å få etablert FOU-prosjekter med de rette aktører og finansiering, og en ikke alltid like lett kombinasjon med jobb.
    [Show full text]
  • The State Ownership Report 2018
    THE STATE OWNERSHIP REPORT 2018 1 Contents In case of discrepancy between the original text in Norwegian Contents and the English translation, the Norwegian text shall prevail. Foreword by the Minister 3 Electronic Chart Centre AS 64 Rogaland Teater AS 104 GIEK Kredittforsikring AS 65 Simula Research Scope and key figures 5 Investinor AS 66 Laboratory AS 105 Key issues for the State as owner 9 Kommunalbanken AS 67 Siva – Selskapet for Industrivekst SF 106 Mantena AS 68 Return and financial values 11 Space Norway AS 107 Nysnø Klimainvesteringer AS 69 Statnett SF 108 Key figures describing Posten Norge AS 70 Statskog SF 109 financial performance 17 Statkraft SF 71 Staur gård AS 110 Vygruppen AS 72 Corporate governance 23 Store Norske Spitsbergen Kulkompani AS 111 You are what you measure 29 CATEGORY 4 Talent Norge AS 112 Diversity as a – Sectoral policy objectives Trøndelag Teater AS 113 competitive advantage 35 Andøya Space Center AS 76 Universitetssenteret Avinor AS 77 på Svalbard AS 114 AS Vinmonopolet 115 CATEGORY 1– Bane NOR SF 78 Commercial objectives Bjørnøen AS 79 Carte Blanche AS 80 Regional health authorities Ambita AS 42 AS Den Nationale Scene 81 Helse Midt-Norge RHF 118 Baneservice AS 43 Den Norske Opera & Ballett AS 82 Helse Nord RHF 119 Entra ASA 44 Eksportkreditt Norge AS 83 Helse Sør-Øst RHF 120 Flytoget AS 45 Enova SF 84 Helse Vest RHF 121 Mesta AS 46 Entur AS 85 Other companies 123 Gassco AS 86 CATEGORY 2 – Commercial objectives and ensuring head office functions Gassnova SF 87 Appendices 125 in Norway Graminor AS 88 Remuneration
    [Show full text]